For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

17th May 10

Pharmaxis announces sustained benefit in cystic fibrosis following long term bronchitol treatment

Pharmaxis today announced significant headline results for the final stage of its international Phase III trial of Bronchitol (inhaled mannitol) in people with cystic fibrosis.


Read full media release - pdf